Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  510 results for ""Endometrial Neoplasms""

Your Filters

Subject : antineoplastic combined chemotherapy protocols
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Immune checkpoint inhibitor combinations for patients with advanced endometrial cancer: a network meta-analysis and cost-utility analysis.

  • Authors : Zhu Y; Department of Oncology, Xiangya Hospital Central South University, Changsha, Hunan, China.; Liu K

Subjects: Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/economics ; Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/therapeutic use ; Cost-Benefit Analysis*

  • Source: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2024 Oct 07; Vol. 34 (10), pp. 1570-1579. DatePublisher: BMJ Country of Publication: England NLM ID: 9111626 Publication Model: Electronic Cited Medium: Internet ISSN: 1525-1438 (Electronic)

Record details

Read More Add to Saved list
×
Academic Journal

Imlunestrant, an oral selective estrogen receptor degrader, as monotherapy and combined with abemaciclib, in recurrent/advanced ER-positive endometrioid endometrial cancer: Results from the phase 1a/1b EMBER study.

  • Authors : Yonemori K; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.; Boni V

Subjects: Aminopyridines*/Aminopyridines*/Aminopyridines*/administration & dosage ; Aminopyridines*/Aminopyridines*/Aminopyridines*/adverse effects ; Aminopyridines*/Aminopyridines*/Aminopyridines*/pharmacokinetics

  • Source: Gynecologic oncology [Gynecol Oncol] 2024 Dec; Vol. 191, pp. 172-181. Date of Electronic Publication: 2024 Oct 22.Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Impact of chemotherapy on patients with mismatch repair deficient advanced endometrial carcinomas-a meta-analysis.

  • Authors : Tjokrowidjaja A; National Health and Medical Research Council Clinical Trials Centre, The University of Sydney, Sydney 2050, Australia.; Australia New Zealand Gynecological Oncology Group, Camperdown 2050, Australia.

Subjects: Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/therapeutic use ; Carboplatin*/Carboplatin*/Carboplatin*/therapeutic use ; Carboplatin*/Carboplatin*/Carboplatin*/administration & dosage

  • Source: JNCI cancer spectrum [JNCI Cancer Spectr] 2024 Nov 01; Vol. 8 (6).Publisher: Oxford University Press Country of Publication: England NLM ID: 101721827 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

ENGOT-en11/GOG-3053/KEYNOTE-B21: a randomised, double-blind, phase III study of pembrolizumab or placebo plus adjuvant chemotherapy with or without radiotherapy in patients with newly diagnosed, high-risk endometrial cancer.

Subjects: Endometrial Neoplasms*/Endometrial Neoplasms*/Endometrial Neoplasms*/pathology ; Endometrial Neoplasms*/Endometrial Neoplasms*/Endometrial Neoplasms*/drug therapy ; Endometrial Neoplasms*/Endometrial Neoplasms*/Endometrial Neoplasms*/therapy

  • Source: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2024 Nov; Vol. 35 (11), pp. 968-980. Date of Electronic Publication: 2024 Sep 14.Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041

Record details

Read More Add to Saved list
×
Academic Journal

Cost-effectiveness of pembrolizumab plus chemotherapy for advanced endometrial cancer.

  • Authors : Huo G; Department of Thoracic Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.; National Clinical Research Center for Cancer, Tianjin, China.

Subjects: Endometrial Neoplasms*/Endometrial Neoplasms*/Endometrial Neoplasms*/drug therapy ; Endometrial Neoplasms*/Endometrial Neoplasms*/Endometrial Neoplasms*/economics ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/economics

  • Source: Journal of gynecologic oncology [J Gynecol Oncol] 2024 Nov; Vol. 35 (6), pp. e86. Date of Electronic Publication: 2024 Apr 08.Publisher: Asian Society of Gynecologic Oncology Country of Publication: Korea (South) NLM ID: 101483150 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Efficacy and safety of immune checkpoint inhibitors for advanced or recurrent endometrial cancer: a systematic review and network meta-analysis.

  • Authors : Huang D; Department of Pharmacy, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang, China. .; Li S

Subjects: Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/adverse effects ; Endometrial Neoplasms*/Endometrial Neoplasms*/Endometrial Neoplasms*/drug therapy

  • Source: BMC cancer [BMC Cancer] 2024 Oct 21; Vol. 24 (1), pp. 1298. Date of Electronic Publication: 2024 Oct 21.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Re-administration of platinum-based chemotherapy for recurrent endometrial cancer: an ancillary analysis of the SGSG-012/GOTIC-004/Intergroup study.

  • Authors : Nagao S; Department of Obstetrics and Gynecology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan. .; Nishio S

Subjects: Endometrial Neoplasms*/Endometrial Neoplasms*/Endometrial Neoplasms*/drug therapy ; Endometrial Neoplasms*/Endometrial Neoplasms*/Endometrial Neoplasms*/pathology ; Neoplasm Recurrence, Local*/Neoplasm Recurrence, Local*/Neoplasm Recurrence, Local*/drug therapy

  • Source: International journal of clinical oncology [Int J Clin Oncol] 2024 Oct; Vol. 29 (10), pp. 1594-1601. Date of Electronic Publication: 2024 Jul 13.Publisher: Springer-Verlag Tokyo Country of Publication: Japan NLM ID: 9616295 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Low-dose lenvatinib and anti-programmed cell death protein-1 combination therapy in patients with heavily pre-treated recurrent ovarian and endometrial cancer: a pilot study.

  • Authors : Shang X; Department of Obstetrics and Gynecology, National Clinical Research Center for Obstetric & Gynecologic Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.; Su H

Subjects: Endometrial Neoplasms*/Endometrial Neoplasms*/Endometrial Neoplasms*/drug therapy ; Endometrial Neoplasms*/Endometrial Neoplasms*/Endometrial Neoplasms*/pathology ; Phenylurea Compounds*/Phenylurea Compounds*/Phenylurea Compounds*/administration & dosage

  • Source: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2024 Aug 05; Vol. 34 (8), pp. 1203-1210. Date Publisher: BMJ Country of Publication: England NLM ID: 9111626 Publication Model: Electronic Cited Medium: Internet ISSN: 1525-1438 (Electronic)

Record details

Read More Add to Saved list
×
Academic Journal

Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial.

Subjects: Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/administration & dosage ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/adverse effects ; Endometrial Neoplasms*/Endometrial Neoplasms*/Endometrial Neoplasms*/drug therapy

  • Source: The Lancet. Oncology [Lancet Oncol] 2024 Sep; Vol. 25 (9), pp. 1135-1146. Date of Electronic Publication: 2024 Aug 02.Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Cost-effectiveness of atezolizumab plus chemotherapy for advanced/recurrent endometrial cancer.

  • Authors : Huo G; Department of Thoracic Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.; National Clinical Research Center for Cancer, Tianjin, China.

Subjects: Cost-Benefit Analysis* ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/economics ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/administration & dosage

  • Source: Journal of gynecologic oncology [J Gynecol Oncol] 2024 Sep; Vol. 35 (5), pp. e83. Date of Electronic Publication: 2024 Apr 03.Publisher: Asian Society of Gynecologic Oncology Country of Publication: Korea (South) NLM ID: 101483150 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
  • 1-10 of  510 results for ""Endometrial Neoplasms""